Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Carafate Generic Name & Formulations
Legal Class
Rx
General Description
Sucralfate 1g; scored tabs.
Pharmacological Class
Cytoprotective agent.
See Also
How Supplied
Tabs—100; Susp—14oz
Manufacturer
Carafate Indications
Indications
Short-term (up to 8 weeks) treatment of active duodenal ulcer. Maintenance of healed duodenal ulcers (tabs only).
Carafate Dosage and Administration
Adult
Active: 1g 4 times daily on an empty stomach for 4–8 weeks. Maintenance: 1g 2 times daily.
Children
Not established.
Carafate Contraindications
Not Applicable
Carafate Boxed Warnings
Not Applicable
Carafate Warnings/Precautions
Warnings/Precautions
Susp: administer by oral route only; do not give intravenously. Monitor for glycemia in diabetic patients. Chronic renal failure. Dialysis. Tabs: swallowing impairment (eg, recent or prolonged intubation, tracheostomy, history of aspiration, dysphagia, others). Pregnancy (Cat.B). Nursing mothers.
Carafate Pharmacokinetics
Elimination
Renal.
Carafate Interactions
Interactions
Avoid antacids within 30mins of dosing. May reduce absorption of tetracyclines, quinidine, levothyroxine, phenytoin, cimetidine, digoxin, ciprofloxacin, norfloxacin, ketoconazole, ranitidine, theophylline; dose concomitant drugs 2hrs before sucralfate. Additive aluminum load with aluminum-containing antacids. Monitor warfarin.
Carafate Adverse Reactions
Adverse Reactions
Constipation.
Carafate Clinical Trials
See Literature
Carafate Note
Not Applicable
Carafate Patient Counseling
See Literature
